Trending
Most Popular
U.S. Stocks Propel Forward On Monday – February 9, 2026 -( $AVGO $DV $FLYX $META $NOK $NVDA $OKLO $OPEN $ORCL $PLTR $RIO $TSLA $TSM Rise!)
US stocks extended last week’s relief rally on Monday, with megacap tech doing most of the…
by John F. Heerdink, Jr. February 10, 2026
Dow Breaks 50,000 as Wall Street Limps, Then Leaps Into the Weekend – February 6, 2026 -( $DIA $EPRX $FLYX $LLY $MCD $MANE $MODD $NOK $RIO Rise!)
Wall Street closed the week ending Feb. 6, 2026 looking a bit like a trader after…
by John F. Heerdink, Jr. February 6, 2026
Agriculture & Energy
From Benicia to the Bahamas: The Surprising Supply Chain Behind California’s Gas Spike -( $PSX $VLO )
California drivers are discovering that “California premium” at the pump comes with a 40‑cent surprise this…
by John F. Heerdink, Jr. February 16, 2026
Meta’s $10 Billion Indiana Data Bet: When AI Meets the Corn Belt -( $META )
Meta’s decision to plant a more-than-1-gigawatt data center in Lebanon, Indiana, reads like a statement that…
by John F. Heerdink, Jr. February 12, 2026
Leidos’ $2.4 Billion Power Play: Why the ENTRUST Deal Could Supercharge Its Energy Future ( $LDOS $SPY )
Leidos (LDOS) is betting that the future of power isn’t just about electrons—it’s about engineering, data…
by John F. Heerdink, Jr. February 2, 2026
Biotech & Healthcare
Eupraxia’s Latest Raise: A Diffusphere-Fueled War Chest Aims at GI Disease -( $EPRX $IBB $XBI $SNY)
In a market that has grown wary of “story stocks,” Eupraxia Pharmaceuticals (NASDAQ: EPRX) just delivered…
by John F. Heerdink, Jr. 19 hours ago
GeoVax Expands Gedeptin Strategy: Riding Merck’s Keytruda Wave in a $200 Billion IO Market -( $GOVX $MRK $IBB $XBI )
GeoVax’s (NASDAQ: GOVX) latest move to lock down combination rights for its Gedeptin cancer platform reads…
by John F. Heerdink, Jr. 3 days ago
Year of the Horsepower: Insulet’s Earnings Sprint and Modular Medical’s Quiet Canter -( $MODD $PODD )
Insulet’s (PODD) latest numbers read like the balance sheet of a very determined racehorse: fast, disciplined,…
by John F. Heerdink, Jr. 3 days ago
Consumer Goods & Trends
Healthcare’s Favorite Scrub Maker Is Quietly Stitching a Bigger Future for FIGS
FIGS, Inc. (NYSE: FIGS) has built a rare position in retail: a founder-led, direct-to-consumer brand that…
by John F. Heerdink, Jr. 2 days ago
Carvana’s Earnings Hit a Speed Bump: Record Sales, Market Throws On the Parking Brake -( $CVNA $SPY )
Carvana’s (CVNA) latest earnings report delivered record sales and solid profits, but Wall Street still sent…
by John F. Heerdink, Jr. 3 days ago
The Big Mac Meets the Skinny Pill: How McDonald’s and Eli Lilly Are Sharing the Same Consumer -( $LLY $MCD )
McDonald’s (MCD) has handled low-carb fads, kale revolutions, and the brief reign of cauliflower rice, but…
by John F. Heerdink, Jr. February 12, 2026
Financials & Fintech
Earnings, Algorithms, PCE and Iran: What Could Possibly Go Wrong? -( $DIA $QQQ $SPY $VIX )
Wall Street closed Thursday walking a now-familiar tightrope: cheering resilient earnings and AI-fueled innovation while eyeing…
by John F. Heerdink, Jr. 2 days ago
How 2026 Turns Savers Into Shoppers in the New Banking Economy For Gen Z & Beyond
The coming year in banking looks surprisingly upbeat for savers who are willing to click, compare,…
by Vista Partners LLC December 28, 2025
Steve Ballmer’s Intuit Dome Unveiled: $2 Billion HQ Redefines Sports Arenas and Corporate Campuses -( $INTU $MSFT $SPY )
Intuit’s (INTU) latest splash isn’t in fintech, but in construction—where the budget now garners more buzz…
by Vista Partners LLC November 18, 2025
Investing & Inspiration
Eupraxia’s Latest Raise: A Diffusphere-Fueled War Chest Aims at GI Disease -( $EPRX $IBB $XBI $SNY)
In a market that has grown wary of “story stocks,” Eupraxia Pharmaceuticals (NASDAQ: EPRX) just delivered…
by John F. Heerdink, Jr. 19 hours ago
Healthcare’s Favorite Scrub Maker Is Quietly Stitching a Bigger Future for FIGS
FIGS, Inc. (NYSE: FIGS) has built a rare position in retail: a founder-led, direct-to-consumer brand that…
by John F. Heerdink, Jr. 2 days ago
Earnings, Algorithms, PCE and Iran: What Could Possibly Go Wrong? -( $DIA $QQQ $SPY $VIX )
Wall Street closed Thursday walking a now-familiar tightrope: cheering resilient earnings and AI-fueled innovation while eyeing…
by John F. Heerdink, Jr. 2 days ago
Materials & Natural Resources
Critical Minerals, Critical Money: How Japan and M2i–Volato Aim to Cash In on a $320 Billion Market -( $MTWO $SOAR )
Japan is about to become one of America’s biggest energy backers, wiring in a $36 billion…
by John F. Heerdink, Jr. 3 days ago
Corning and Meta’s $6 Billion Fiber Tie-Up: AI’s New Glass Half Full -( $AMZN $GLW $META $NVDA $GOOG $MSFT )
Corning (GLW) and Meta (META) just inked a multiyear, up to $6 billion agreement that effectively…
by John F. Heerdink, Jr. January 27, 2026
Gold’s Best Week in Years and Silver’s Dash Toward $100: Is This the Start of a New Metals Supercycle? -( $GLD $SLV )
Gold just logged its best week since 2020 while silver flirted with triple digits, turning the…
by John F. Heerdink, Jr. January 23, 2026
Technology & Beyond
February 20, 2026- Tariffs, Tantrums, and a 1.1% Gain: Wall Street’s Surprisingly Chill Week -( $EPRX $NOK $NVDA $OPEN Rise!)
US stocks finished the holiday‑shortened week ended Friday, February 20, 2026 higher, as a landmark Supreme…
by John F. Heerdink, Jr. 20 hours ago
February 19, 2026- Soft Landing, Hard Reality: What Today’s Sell‑Off Is Whispering to Patient Investors -( $DV $INTG $MODD $MTWO $NOK $OPEN $SER $VIX Rise!)
U.S. stocks traded lower on Thursday, with major indexes pulling back after recent gains as investors…
by John F. Heerdink, Jr. 2 days ago
February 18, 2026 – Stock Market Update: Tech Rebounds, AI Leaders and Small‑Cap Biotechs Move -( $DV $MCD $NOK $NVDA $OPEN $SER Rise!)
U.S. stocks extended their rebound on Tuesday, February 18, 2026, with the major indexes logging another…
by John F. Heerdink, Jr. 3 days ago
Latest News
Eupraxia’s Latest Raise: A Diffusphere-Fueled War Chest Aims at GI Disease -( $EPRX $IBB $XBI $SNY)
In a market that has grown wary of “story stocks,” Eupraxia Pharmaceuticals (NASDAQ: EPRX) just delivered…
by John F. Heerdink, Jr. 19 hours ago
February 20, 2026- Tariffs, Tantrums, and a 1.1% Gain: Wall Street’s Surprisingly Chill Week -( $EPRX $NOK $NVDA $OPEN Rise!)
US stocks finished the holiday‑shortened week ended Friday, February 20, 2026 higher, as a landmark Supreme…
by John F. Heerdink, Jr. 20 hours ago
Healthcare’s Favorite Scrub Maker Is Quietly Stitching a Bigger Future for FIGS
FIGS, Inc. (NYSE: FIGS) has built a rare position in retail: a founder-led, direct-to-consumer brand that…
by John F. Heerdink, Jr. 2 days ago
Must-Watch Videos
Most Read
Featured
Eupraxia’s Latest Raise: A Diffusphere-Fueled War Chest Aims at GI Disease -( $EPRX $IBB $XBI $SNY)
In a market that has grown wary of “story stocks,” Eupraxia Pharmaceuticals (NASDAQ: EPRX) just delivered…
by John F. Heerdink, Jr. 19 hours ago
Healthcare’s Favorite Scrub Maker Is Quietly Stitching a Bigger Future for FIGS
FIGS, Inc. (NYSE: FIGS) has built a rare position in retail: a founder-led, direct-to-consumer brand that…
by John F. Heerdink, Jr. 2 days ago
Amazon’s Amazing Theatrical Expansion – $AMZN $SPY
Amazon has unveiled ambitious plans to significantly increase its theatrical movie releases starting in 2025, aiming…
by John F. Heerdink, Jr. April 3, 2025
Lawrence Summers Warns of Economic Storm Clouds Ahead – $SPY $QQQ $DIA $VIX
Former Treasury Secretary Lawrence Summers has delivered a sobering outlook for the U.S. economy, suggesting that…
by John F. Heerdink, Jr. April 8, 2025
